Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01751022 · ClinicalTrials.gov registry record · NA
Attain Performa(TM) Quadripolar Lead Study
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 1,202
- Enrollment target
NCT01751022 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 1,202 participants.
The verdict
NCT01751022, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,202 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the safety and efficacy of the Medtronic Attain Performa Quadripolar Leads (Model 4298, 4398, and 4598) during and post the implant procedure. This study will also assess the interactions of the Attain Performa leads with the entire Medtronic CRT-D system.
Interventions
- DEVICE Device: Attain Performa Pacing Lead (along with a standard CRT-D system)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,202 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01751022
The ClinicalTrials.gov registry entry for NCT01751022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Device: Attain Performa Pacing Lead (along with a standard CRT-D system) is the first listed.
NCT01751022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01751022 about?
NCT01751022 is a clinical study titled "Attain Performa(TM) Quadripolar Lead Study". The purpose of the study is to evaluate the safety and efficacy of the Medtronic Attain Performa Quadripolar Leads (Model 4298, 4398, and 4598) during and post the implant procedure. This study will also assess the interactions of the Attain Performa leads with the entire Medtronic CRT-D system.
What is the current status of trial NCT01751022?
This trial is currently completed. It is a NA study. The enrollment target is 1,202 participants. The study started on 2012-12. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01751022?
The interventions under investigation include: Device: Attain Performa Pacing Lead (along with a standard CRT-D system) (DEVICE).
Who is sponsoring clinical trial NCT01751022?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.